Alcami /AAI Pharma

Discussion in 'Alcami' started by anonymous, Jun 17, 2016 at 3:29 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest


    Alcami has the appearance of compliance. Knowing where to dig will reveal the maggots of borderline compliance hiding under rocks. Most of the illegal stuff was related to AAI's (the former company name) failed attempt to become a pharmaceutical company and the bankruptcy that followed - thanks Fred.

    Capacity is tight in the contract lab world, even a third rate bottom feeder can still make a buck off of smaller companies or someone with a tight timeline that can't wait for Eurofins (Lancaster), Covance, Catalent, PPD etc. to have a slot open up.

    You get what you pay for; caveat emptor.
     

  2. anonymous

    anonymous Guest

    Alcami sucks
     
  3. anonymous

    anonymous Guest

    Production and efficiency is much better now that the idiot in solid dose is gone. Revamping the entire department has been a breath of fresh air. Quality as improved significantly.
     
  4. anonymous

    anonymous Guest

    Yeah right. The idiot in charge is still here, a bit father away, but still here. We can't spell Qwality with out you! And you still suck.
     
  5. anonymous

    anonymous Guest


    Hehehe....thanks for the opinion SK. One wave of your magic wand and all of the quality and personnel problems go away. What a relief.
     
  6. anonymous

    anonymous Guest

    It still is really bad, back stabbing syncophants for management, clueless a-holes who only care about money. What a joke.
     
  7. anonymous

    anonymous Guest

    Work all year and told that the best to expect is half a bonus. All year we hear how we have to work harder because we're going to be the best in industry and then get screwed at the finish line. Best at what, turnover of employees? It is not a big shock to see why half the workers have left this septic field. Think about that, this has happened at ALL the sites. And where did those salaries go? You got it. This is a prison camp, a place where they work you till you die. And if you survive you get to work some more. The management here is the worst ever, they watch these and other boards looking to take down posts that show them for what they are. They do not care about quality (that is an afterthought at best), they care about money, money, money. And it ain't for you.
     
  8. anonymous

    anonymous Guest

    Lying useless aholes that mistreat everyone they meet, that is what we have for "management". With that sort of leaders you should not expect anything more that nothing. No recognition for you hard work, no reward for your sacrifices, no money for you. Remember you OWE them for the honor and privilege of being abused by these narcissists. Leave and find a different job, it will pay better and you will be happier. I did.
     
  9. anonymous

    anonymous Guest

    If you get your work done in ten hours, look around and do somebody else's work! Brilliant management scheme to help us do more work for the same shit pay. This would be funny shit on The Onion.
     
  10. anonymous

    anonymous Guest

    You slacker!!! How dare you work only 10 hours a day? Where is your loyalty to the company? No bonus for you!
     
  11. anonymous

    anonymous Guest

    Spelled bone-us.
    What is up with this place? No one is ever really happy, and when the heavyweights come around you feel the tension like electricity. People are actually scared. How in the hell does that make for a good working groupof people?
    Relax people, it's only a job.
     
  12. anonymous

    anonymous Guest

    Update: they stopped hiring replacements, losers or not. That is all. Out.
     
  13. anonymous

    anonymous Guest

    Ha ha ha!
    No "profit sharing" (fucking oxymoron here) for you!
    What a great place to start.
    True story - recruiter calls today and we start talking. Finds out I work at Alcami. No question as to why I want to get out of this SHITHOLE.
     
  14. anonymous

    anonymous Guest

    People are trading this stuff out in the open.
    Zero management other than get shit done.
     
  15. anonymous

    anonymous Guest

    get shit done NOW!

    Forget about your family and the weekend, work harder.
     
  16. anonymous

    anonymous Guest

    Got the shit part right.
    What is a family?
    What days of the week are the weekend?
     
  17. anonymous

    anonymous Guest

    Azopharma did the same stuff, they crashed and burned all of their clients. Thanks Phil & Kim, they started here at allclammy when it was still AAI.
     
  18. anonymous

    anonymous Guest

    The bottom line is money. Lonza, Alcami, it's all the same modus operandi, they were hired to polish up the turd for sale.
    Good luck, all.
     
  19. anonymous

    anonymous Guest

    Money may have been the bottom line at Lonza and appears to be the bottom line at Alcami. What the client's got at Lonza was a warning letter from the FDA. That was the kiss of death for Eisai (Ontak) and Tercica (Increlex), just ask SK about his role in the success of those client's and their products. The harm to other clients was not as public as those two, SK will do more damage at allclammy.
     
  20. anonymous

    anonymous Guest

    "Lonza, a Swiss contract manufacturer, is going to begin to shut down operations at a troubled biologics facility that is located in Hopkinton MA. This will eventually lead to the loss of about 250 jobs. Originally, there was no time frame for the move, but now the company is going to start the phase out in September.
    Lonza has been struggling to get the facility into compliance with cGMP regulations, which has created supply problems for some clients. The plant has had cGMP problems since 2011, when it got a warning letter from FDA. That letter focused on bad batches of an API that it makes for Ontak, which is a cancer drug made by Eisai. However, it is the drugmaker Ipsen, based in France, that is reporting supply problems that are related to this plant. In the spring, it stated that they were having problems making the orphan drug Increlex because of the problems at this facility making the API. This suggests to us that Lonza has had serious problems overcoming cGMP concerns at the plant."